Recombinant Antibodies
Hear over 50 speakers deliver cutting edge data
Our Recombinant Antibodies Congress has quickly established itself as THE leading European event for sharing cutting edge information on antibody research and developments.
With over 40 in depth case studies delivered by no less than 50 industry experts, AND 14+ hours of informal networking opportunities and exhibition viewing time, attending Recombinant Antibodies 2010 is a sure way to ensure your organisation isn’t left behind in this fast moving industry.
Conference Highlights
FREE with a 5 day pass
Evening Seminar, Discussion Session and Dinner: Tuesday 15 June 2010
BUSINESS OF ANTIBODIES
Mergers, Acquisitions and Licensing Trends
With increased demand from big pharmaceutical companies for biotherapeutics and their wide-ranging strategies for securing access to such products, particular emphasis will be placed on M&A and licensing.
Expert Speakers Include:
Expert Speakers Include:
Dr William Strohl
VP, Biologics Research
J&J, USA
|
Dr James Larrick
Scientific Director
Panorama Research Institute, USA
|
Dr Arne Skerra
Professor & Founder
Pieris AG, Germany
|
Dr Victor Goldmacher
Senior Director, Cell Biology
ImmunoGen, USA
|
Dr Randolf Kerschbaumer
Associate Director R&D
Baxter Innovations
|
Dr Nathalie Corvaia
Research Director
Pierre Fabre, France
|
Prof Dario Neri
Chemistry & Applied Biosciences
ETH Zurich
|
Prof Roy Jefferis
Immunity and
Infection University of Birmingham, UK |
Delegates may choose from 2, 3, 4, or 5 day pass:
Day 1 - Antibody Generation and Screening Techniques
Day 2 - Antibody Engineering, Fragments, Scaffolds and Targets
PLUS - Evening Seminar: Businesses of Antibodies
Day 3 - Bispecific Biologics, Drug Conjugates and Imaging
Day 4 - Patents, Regulatory Considerations and Clinical Developments
Day 5 - A-Z of Therapeutic Antibodies
Keynote Speakers
• Dr William Strohl, VP, Biologics Research, J&J Biotechnology Center of Excellence, USA
• Dr James W. Larrick, Scientific Director, Panorama Research Institute (PRI), USA
• Professor Dario Neri, Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland
High Speed Networking
Tuesday 15 June 2010 at 15:50
With HIGH SPEED NETWORKING you can make more new business
contacts in one session than most people will make in 6 months!
Spotlight Presentation Sponsors
Exhibitors
Media Partners
Spotlight Presentation Sponsors
Special Offers - applicable to biopharm & pharma companies (excludes service providers)
Have your Say! Join us at Linked In
Poll
What area of the EU’s current regulatory framework on biosimilars is most in need of reform?
Please select an answer
Reviews
"The leading Antibody conference in Europe"
"It gave me an excellent opportunity to catch up with all the current developments, technology trends and clinical advances in the field of rec. antibodies. It was also an opportunity to meet many of the key figures in the area"
"A valuable survey of preclinical and clinical programs with antibodies and antibody-like variants"
